Yasons Chemex Care Limited (NSE:YCCL)
10.80
0.00 (0.00%)
Jan 21, 2026, 3:14 PM IST
Yasons Chemex Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Operating Revenue | 964.25 | 765.33 | 692.43 | 367.73 | 250.52 | 177.74 | Upgrade |
Other Revenue | 0.29 | 0.29 | 2.89 | 20.18 | 0.12 | 0.03 | Upgrade |
| 964.54 | 765.62 | 695.33 | 387.9 | 250.64 | 177.76 | Upgrade | |
Revenue Growth (YoY) | 57.14% | 10.11% | 79.25% | 54.77% | 41.00% | -8.45% | Upgrade |
Cost of Revenue | 944.65 | 736.68 | 649.45 | 355.19 | 225.71 | 152.46 | Upgrade |
Gross Profit | 19.89 | 28.94 | 45.88 | 32.71 | 24.93 | 25.3 | Upgrade |
Selling, General & Admin | 5.29 | 7.59 | 8.16 | 1.47 | 1.65 | 0.76 | Upgrade |
Other Operating Expenses | -12.09 | -18.5 | 2.24 | -1.08 | 3.11 | 4.84 | Upgrade |
Operating Expenses | -4.52 | -7.13 | 14.69 | 1.4 | 6.05 | 7.08 | Upgrade |
Operating Income | 24.41 | 36.07 | 31.19 | 31.32 | 18.88 | 18.22 | Upgrade |
Interest Expense | -11.96 | -12.65 | -9.97 | -3.58 | -3.07 | -1.69 | Upgrade |
Interest & Investment Income | 0.59 | 0.59 | 0.12 | 0.58 | 1.97 | 1.88 | Upgrade |
Earnings From Equity Investments | - | - | - | 14.35 | 8.04 | 0.32 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 0.03 | - | -0.22 | 0.05 | Upgrade |
Other Non Operating Income (Expenses) | -1.7 | -1.7 | -3.33 | -0.53 | -0.49 | -0.62 | Upgrade |
Pretax Income | 11.34 | 22.31 | 18.04 | 42.14 | 25.11 | 18.16 | Upgrade |
Income Tax Expense | 3.73 | 6.1 | 5.57 | 7.86 | 5.57 | 5.63 | Upgrade |
Earnings From Continuing Operations | 7.6 | 16.21 | 12.48 | 34.28 | 19.54 | 12.54 | Upgrade |
Minority Interest in Earnings | -0.1 | -0.09 | -0.07 | - | - | - | Upgrade |
Net Income | 7.5 | 16.12 | 12.41 | 34.28 | 19.54 | 12.54 | Upgrade |
Net Income to Common | 7.5 | 16.12 | 12.41 | 34.28 | 19.54 | 12.54 | Upgrade |
Net Income Growth | 150.55% | 29.88% | -63.80% | 75.41% | 55.89% | 8.52% | Upgrade |
Shares Outstanding (Basic) | 20 | 19 | 18 | 14 | 14 | 14 | Upgrade |
Shares Outstanding (Diluted) | 20 | 19 | 18 | 14 | 14 | 14 | Upgrade |
Shares Change (YoY) | 10.20% | 9.69% | 24.27% | - | - | - | Upgrade |
EPS (Basic) | 0.37 | 0.83 | 0.71 | 2.42 | 1.38 | 0.89 | Upgrade |
EPS (Diluted) | 0.37 | 0.83 | 0.71 | 2.42 | 1.38 | 0.89 | Upgrade |
EPS Growth | 124.49% | 17.72% | -70.86% | 75.38% | 55.89% | 8.52% | Upgrade |
Free Cash Flow | 23.37 | -25.11 | -162.39 | -2.7 | -0.1 | 20.73 | Upgrade |
Free Cash Flow Per Share | 1.15 | -1.30 | -9.23 | -0.19 | -0.01 | 1.46 | Upgrade |
Gross Margin | 2.06% | 3.78% | 6.60% | 8.43% | 9.95% | 14.24% | Upgrade |
Operating Margin | 2.53% | 4.71% | 4.49% | 8.07% | 7.53% | 10.25% | Upgrade |
Profit Margin | 0.78% | 2.10% | 1.79% | 8.84% | 7.80% | 7.05% | Upgrade |
Free Cash Flow Margin | 2.42% | -3.28% | -23.36% | -0.70% | -0.04% | 11.66% | Upgrade |
EBITDA | 26.69 | 39.85 | 35.48 | 32.33 | 20.18 | 19.71 | Upgrade |
EBITDA Margin | 2.77% | 5.21% | 5.10% | 8.33% | 8.05% | 11.09% | Upgrade |
D&A For EBITDA | 2.28 | 3.78 | 4.29 | 1.01 | 1.29 | 1.49 | Upgrade |
EBIT | 24.41 | 36.07 | 31.19 | 31.32 | 18.88 | 18.22 | Upgrade |
EBIT Margin | 2.53% | 4.71% | 4.49% | 8.07% | 7.53% | 10.25% | Upgrade |
Effective Tax Rate | 32.94% | 27.34% | 30.85% | 18.66% | 22.18% | 30.99% | Upgrade |
Revenue as Reported | 987.34 | 793.16 | 701.99 | 410.06 | 261.7 | 180.48 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.